The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Reducing Global Mortality And Severity Of Disease In Newborn Infants Through Innovation And Holistic Interventions
Funder
National Health and Medical Research Council
Funding Amount
$2,060,520.00
Summary
Infants born prematurely often encounter problems affecting the growth, development and function of multiple body systems. This multi-organ disease usually results from infection, inflammation, and excessive or insufficient oxygen. Importantly, many premature infants are born in low-resource settings. This fellowship aims to reduce global mortality and multi-organ disease in preterm infants using simple, holistic and low-cost interventions that directly target the underlying causative factors.
Early Life Exposures And Chronic Disease: Mechanisms And Preventative Strategies
Funder
National Health and Medical Research Council
Funding Amount
$2,714,215.00
Summary
The world is in the grips of an epidemic of chronic disease and exposure to pollution in early life is partly responsible. To change this situation we need to understand and mitigate the mechanisms linking early life pollution exposure to life-long disease risk. My research will provide direct evidence of how pollution increases disease risk and design and implement strategies to reduce this, with an emphasis on asthma, cystic fibrosis and chronic respiratory disease.